Peptide

Tesamorelin

Tesamorelin (GHRH Analog)

Research Use Only · Not for Human Consumption

Tesamorelin is a synthetic analog of endogenous GHRH (44 amino acids) stabilized by a trans-3-hexenoic acid group at the N-terminus. This modification protects the peptide from rapid degradation by dipeptidyl peptidase IV (DPP-IV), extending its half-life compared to native GHRH. Tesamorelin has been studied for its ability to stimulate GH secretion and reduce visceral adipose tissue in metabolic research models.

Key Facts

Modification
Trans-3-hexenoic acid N-terminal
Protects against
DPP-IV degradation
Type
Stabilized GHRH analog
Storage
-20°C lyophilized

Research Applications

  • GHRH receptor activation studies
  • Visceral fat reduction research models
  • GH pulsatility research
  • DPP-IV stability studies in peptide design

Frequently Asked Questions

Stock Tesamorelin on Your Research Compound Store

PeptiCommerce provides turn-key access to COA-documented research compounds. Your branded WooCommerce store with P2P and crypto payment support, ready in under 72 hours.

Get Started →
Back to Glossary

Get the Research Peptide Business Playbook

10-part email series on launching a compliant, profitable research peptide brand — market data, COA strategy, pricing, and platform walkthrough. Free.

No spam. Unsubscribe anytime. Research-use-only content only.